Antipsychotic use in pregnancy. What are the best treatment options?
Both the rapid emergence of new antipsychotic medications and the increasing fertility rate among women with psychotic disorders have contributed to the growing clinical importance of the treatment of pregnant women who have psychotic illnesses. The treatment of this patient population must always take into consideration the effect of that treatment on the fetus. With regard to the high risk of decompensation during pregnancy and postpartum, continuous antipsychotic medication is needed using the minimum effective dose. The use of high-potency agents appears to be preferable for first-line management, as there are few data regarding the use of atypical agents such as clozapine in pregnancy. Guidelines for treating pregnant women with psychoses vary little from those for nonpregnant patients. Clinicians must always carefully weigh up the risks and benefits for each patient on an individual basis.
Trixler
M
M
Department of Psychiatry and Medical Psychology, University Medical School of Pécs, Hungary.
Tényi
T
T
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000494:pharmacology; D001519:Behavior / Q000187:drug effects; D001942:Breast Feeding; D003024:Clozapine / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D049590:Postpartum Period / Q000187:drug effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000188:drug therapy*; D018570:Risk Assessment
D014150:Antipsychotic Agents; D003024:Clozapine